Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

23 Jan 2021 Evaluate

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the company will be held on Tuesday, 2nd February 2021 to consider and approve un-audited consolidated & standalone financial results of the Company for the third quarter ended 31st December 2020.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1763.70
Dr. Reddys Labs. 1347.20
Cipla 1366.50
Lupin 1988.45
Zydus Lifesciences 1180.70
View more..